Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- befree-2016 importedOn "2016-02-19" NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_assertion wasGeneratedBy ECO_0000203 NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_assertion wasDerivedFrom befree-2016 NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_assertion SIO_000772 22021366 NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_assertion evidence source_evidence_literature NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.
- NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_assertion description "[Altogether, our data suggest that AMPK is an attractive target for the treatment of BCR-ABL-expressing malignancies and raise the potential for use of AMPK activators in the treatment of refractory chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933111.RAwmls9SeB5w39pCN4ktlBhRhvxwcmCLIR9-xjR5914ts130_provenance.